Knowledge Assessment: How to Write a PBRER

A routine reconciliation activity with no effect on scientific understanding A minor formatting change to an internal database report Completion of a major signal evaluation that may affect product information The receipt of a routine periodic data transfer with no clinically important findings

Which sections can be copied from the previous report and which tables can be shortened? Which new information may modify an important risk, affect product information or influence the overall benefit-risk balance? Which source has the largest number of cases and which contributor can write the fastest? How can every observation be given identical emphasis and wording?

Correction of typographical errors and formatting defects Verification that the report communicates a coherent, balanced and scientifically defensible assessment Confirmation that every paragraph contains a numerical result Reduction of the report to the shortest possible length

They should describe the issue as causally established because cases were reported They should remain aligned with the signal conclusion unless additional evidence is introduced They should omit the signal evaluation to avoid repetition They should reverse the conclusion whenever the event is clinically serious

High-level scientific review makes formal quality control unnecessary Formal quality control replaces the need to assess the scientific narrative High-level scientific review complements formal quality control by evaluating coherence, interpretation and benefit-risk reasoning The two activities are interchangeable and should be performed only once

To provide a chronological inventory of all pharmacovigilance activities completed during the period To evaluate whether new cumulative evidence changes the medicinal product's benefit-risk balance To demonstrate that every section of the regulatory template has been completed To summarise only serious adverse reactions received during the reporting interval

It provides the only acceptable wording for the new report It establishes the baseline against which new evidence can be interpreted It replaces the need to review current signal assessments It determines that all risks discussed previously must remain equally important

Each section is written independently, with the integrated assessment added at the end The report follows a logical progression in which evidence and interpretation build toward the overall conclusion All sections use the same amount of detail regardless of clinical importance The report is organised primarily by the date on which each activity occurred

To perform the first check of factual accuracy and section ownership To proofread the report after scientific review has been completed To determine whether the completed report presents a balanced, internally consistent and defensible scientific assessment To ensure that the integrated benefit-risk conclusion introduces new interpretations not discussed earlier

Starting with the first template section and filling in information as it becomes available Collecting every available data point before deciding which scientific issues matter Reviewing the previous PBRER, regulatory outcomes, signal evaluations, product information changes and other important sources Writing the integrated benefit-risk conclusion before reviewing the reporting-period evidence